These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3115927)

  • 1. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
    Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion].
    Munker R; Darsow M; Stötzer O; Kremer JP; Mezger J
    Med Klin (Munich); 1994 May; 89(5):248-51. PubMed ID: 8052178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
    van Hensbergen Y; Broxterman HJ; Hanemaaijer R; Jorna AS; van Lent NA; Verheul HM; Pinedo HM; Hoekman K
    Clin Cancer Res; 2002 Dec; 8(12):3747-54. PubMed ID: 12473585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
    Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.
    Mihăilescu E; Micu D; Cheţa N; Chiriloiu C; Georgescu M; Vilău C
    Med Interne; 1986; 24(3):227-33. PubMed ID: 2430328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of beta-type transforming growth factor activity in human urine obtained from cancer patients.
    Nishimura R; Okumura H; Noda K; Yasumitsu H; Umeda M
    Jpn J Cancer Res; 1986 Jun; 77(6):560-7. PubMed ID: 3089989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomorphological and immunocytochemical study of non-Hodgkin's lymphoma in pleural effusion and ascitic fluid.
    Das DK; Al-Juwaiser A; George SS; Francis IM; Sathar SS; Sheikh ZA; Shaheen A; Pathan SK; Haji BE; George J; Kapila K
    Cytopathology; 2007 Jun; 18(3):157-67. PubMed ID: 17488258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of transforming growth factor activity in effusions from cancer patients.
    Hanauske AR; Arteaga CL; Clark GM; Buchok J; Marshall M; Hazarika P; Pardue RL; Von Hoff DD
    Cancer; 1988 May; 61(9):1832-7. PubMed ID: 3162700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
    Pinto MM
    Acta Cytol; 1986; 30(3):240-4. PubMed ID: 3521174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment: what can effusions teach us?
    Kassis J; Klominek J; Kohn EC
    Diagn Cytopathol; 2005 Nov; 33(5):316-9. PubMed ID: 16240401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ascites and pleural effusion. Study and follow-up of 79 patients].
    Molina M; Ortega G; Vidal L; Montoya JJ; Pérez A; García B
    Rev Esp Enferm Apar Dig; 1989 Oct; 76(4):375-8. PubMed ID: 2595069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.